JD HEALTH
06618
BIDU-SW
09888
JD-SW
09618
ALI HEALTH
00241
BEKE-W
02423
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -7.93%7.47B | 1.58%16.58B | 2.13%8.11B | -9.23%16.32B | -15.30%7.94B | 21.93%17.98B | 62.89%9.37B | 16.84%14.75B | -2.32%5.75B | 18.63%12.62B |
Operating income | -7.93%7.47B | 1.58%16.58B | 2.13%8.11B | -9.23%16.32B | -15.30%7.94B | 21.93%17.98B | 62.89%9.37B | 16.84%14.75B | -2.32%5.75B | 18.63%12.62B |
Cost of sales | 5.69%-7.1B | -2.45%-15.62B | -3.86%-7.53B | 6.09%-15.24B | 14.87%-7.25B | -20.68%-16.23B | -62.65%-8.51B | -16.59%-13.45B | 1.49%-5.23B | -16.71%-11.53B |
Operating expenses | 5.69%-7.1B | -2.45%-15.62B | -3.86%-7.53B | 6.09%-15.24B | 14.87%-7.25B | -20.68%-16.23B | -62.65%-8.51B | -16.59%-13.45B | 1.49%-5.23B | -16.71%-11.53B |
Gross profit | -37.00%366.26M | -10.71%964.03M | -15.97%581.35M | -38.35%1.08B | -19.48%691.82M | 34.84%1.75B | 65.30%859.17M | 19.48%1.3B | -10.01%519.78M | 43.70%1.09B |
Selling expenses | -15.60%-459.27M | 2.76%-857.77M | -2.42%-397.29M | 0.51%-882.12M | 9.11%-387.91M | -28.57%-886.61M | -50.21%-426.79M | -8.90%-689.61M | 7.88%-284.13M | -15.33%-633.24M |
Administrative expenses | -24.49%-131.1M | 2.66%-337.64M | -3.61%-105.31M | -38.71%-346.87M | 8.53%-101.64M | -25.85%-250.07M | -46.68%-111.11M | -9.55%-198.71M | -0.84%-75.75M | -16.89%-181.39M |
Special items of operating profit | -7.68%238.22M | 115.71%193.75M | 126.43%258.03M | -378.33%-1.23B | -500.64%-976.29M | 30.47%442.99M | 17.98%243.68M | -36.01%339.52M | -16.08%206.55M | -43.68%530.57M |
Operating profit | -95.81%14.12M | 97.28%-37.63M | 143.51%336.78M | -230.71%-1.38B | -237.01%-774.01M | 41.00%1.06B | 54.17%564.94M | -6.60%750.02M | -16.75%366.44M | -19.24%803.02M |
Financing cost | -22.76%-78.94M | -8.86%-132.04M | -12.75%-64.3M | 7.31%-121.29M | 6.82%-57.03M | 2.38%-130.85M | -7.24%-61.21M | -21.85%-134.05M | -2.78%-57.08M | -62.54%-110.02M |
Share of profits of associates | 99.71%-3K | 16.35%-3.08M | -66.13%-1.03M | -1,598.78%-3.69M | -211.37%-617K | 130.11%246K | 131.91%554K | 95.94%-817K | 91.76%-1.74M | 81.62%-20.12M |
Share of profit from joint venture company | -109.09%-3K | -562,800.00%-5.63M | 725.00%33K | -133.33%-1K | 180.00%4K | -99.86%3K | -155.56%-5K | 15,257.14%2.15M | 12.50%9K | -17.65%14K |
Earning before tax | -123.88%-64.83M | 88.17%-178.38M | 132.64%271.48M | -262.60%-1.51B | -264.92%-831.66M | 50.16%926.97M | 63.92%504.29M | -8.26%617.31M | -15.39%307.64M | -17.66%672.89M |
Tax | 84.38%-9.88M | 45.34%-63.15M | 17.57%-63.23M | 50.99%-115.52M | 26.03%-76.7M | -20.77%-235.69M | -58.59%-103.7M | -32.90%-195.16M | 6.08%-65.39M | -15.46%-146.85M |
After-tax profit from continuing operations | -135.87%-74.7M | 85.12%-241.52M | 122.93%208.26M | -334.76%-1.62B | -326.76%-908.36M | 63.75%691.27M | 65.36%400.59M | -19.75%422.14M | -17.59%242.25M | -23.76%526.05M |
Earning after tax | -135.87%-74.7M | 85.12%-241.52M | 122.93%208.26M | -334.76%-1.62B | -326.76%-908.36M | 63.75%691.27M | 65.36%400.59M | -19.75%422.14M | -17.59%242.25M | -23.76%526.05M |
Minority profit | -77.64%1.57M | 115.21%10.67M | 8.54%7.03M | -72.63%4.96M | -33.56%6.48M | 58.32%18.12M | 30.59%9.75M | -10.19%11.44M | -3.29%7.47M | 102.50%12.74M |
Profit attributable to shareholders | -137.91%-76.28M | 84.51%-252.19M | 122.00%201.22M | -341.81%-1.63B | -334.07%-914.84M | 63.90%673.16M | 66.46%390.84M | -19.99%410.7M | -17.98%234.79M | -24.92%513.31M |
Basic earnings per share | -145.13%-0.051 | 84.26%-0.17 | 118.71%0.113 | -345.45%-1.08 | -337.80%-0.604 | 62.96%0.44 | 69.33%0.254 | -20.59%0.27 | -21.05%0.15 | -24.44%0.34 |
Diluted earnings per share | -145.13%-0.051 | 84.26%-0.17 | 118.77%0.113 | -345.45%-1.08 | -337.94%-0.602 | 62.96%0.44 | 68.67%0.253 | -20.59%0.27 | -21.05%0.15 | -22.73%0.34 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.